Laboratory of Cardiovascular Fluid Dynamics, Department of Mechanical Industrial and Aerospace Engineering, Concordia University, 1455 de Maisonneuve Blvd. W., Montreal, QC, H3G 1M8, Canada.
Department of Mechanical Engineering, McGill University, Montreal, QC, Canada.
Pediatr Cardiol. 2022 Jan;43(1):45-53. doi: 10.1007/s00246-021-02690-2. Epub 2021 Aug 6.
The optimal timing for management of pediatric patients with moderate aortic valve disease [moderate aortic stenosis (modAS) or moderate aortic regurgitation (modAR)] remains unknown and largely unexplored. Although usually asymptomatic, the risk of increased left ventricular (LV) wall stress, irreversible myocardial fibrosis and sudden death in untreated moderate conditions warrants clearer risk stratification for appropriate timely intervention. In this study, we explore the use of a patient-specific mathematical model to introduce a new evaluative parameter of LV performance in patients with moderate aortic valve disease. Synthetic patient data (N = 520) representing healthy patients, and patients with modAS or modAR were first generated. Then, data from twenty-five pediatric patients were included in this study (healthy = 9; moderate AS = 8; modAR = 8). The effect of modAS or modAR on LV performance was evaluated by LV stroke work (LVSW) efficiency, a new non-invasive parameter. The results demonstrate that healthy patients possess a very high LVSW efficiency (synthetic data: 91 ± 2%, in vivo data: 92 ± 3%). However, modAS patients have a significant reduction in LVSW efficiency (synthetic data: 78 ± 2%, in vivo data: 76 ± 5%, p < 0.05), whereas modAR patients had the lowest LVSW efficiency (synthetic data: 58 ± 3%, in vivo data: 66 ± 7%; p < 0.05). This highlights that patients with moderate aortic valve disease require careful myocardial assessment, regardless of onset of clinical symptoms as their LV performance is significantly reduced. The evaluation of LVSW efficiency offers a promising avenue for future stratification of mixed aortic valve disease for optimal timing of management and intervention.
儿童中度主动脉瓣疾病(中度主动脉瓣狭窄[modAS]或中度主动脉瓣反流[modAR])的管理最佳时机尚不清楚,且在很大程度上尚未得到探索。尽管通常无症状,但未经治疗的中度情况下左心室(LV)壁应力增加、不可逆心肌纤维化和猝死的风险需要更明确的风险分层,以便进行适当的及时干预。在这项研究中,我们探索使用患者特异性数学模型来引入评估中度主动脉瓣疾病患者 LV 功能的新评估参数。首先生成代表健康患者和 modAS 或 modAR 患者的合成患者数据(N=520)。然后,将 25 名儿科患者的数据纳入本研究(健康=9;中度 AS=8;modAR=8)。通过新的非侵入性参数 LV 射血做功(LVSW)效率评估 modAS 或 modAR 对 LV 功能的影响。结果表明,健康患者的 LVSW 效率非常高(合成数据:91±2%,体内数据:92±3%)。然而,modAS 患者的 LVSW 效率显著降低(合成数据:78±2%,体内数据:76±5%,p<0.05),而 modAR 患者的 LVSW 效率最低(合成数据:58±3%,体内数据:66±7%;p<0.05)。这表明,患有中度主动脉瓣疾病的患者需要仔细评估心肌功能,无论临床症状是否发生,因为他们的 LV 功能明显降低。LVSW 效率的评估为未来混合主动脉瓣疾病的分层提供了一个有前途的方法,以确定最佳的管理和干预时机。